iShares U.S. Healthcare ETF

Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to…
Read More...

CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's…
Read More...

The U.S. Food and Drug Administration has approved Eli Lilly's GLP-1 pill, the company said, a major milestone for…
Read More...

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.Mike Blake |…
Read More...

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.Kyle Grillot |…
Read More...

Jim Cramer's advice for investors navigating fallout from the U.S.-Israeli attack on Iran: Be selective. With stocks…
Read More...

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby…
Read More...

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
Read More...